Tag: Mike Bennett

Clene Nanomedicine raises $42.5m for developing nanocatalysts for neurodegenerative diseases

pharmanewsdaily- August 30, 2020

Clene Nanomedicine, which is engaged in developing nanocatalysts for the treatment of bioenergetic failure associated with neurodegenerative diseases, has raised $42.5 million in a Series ... Read More